An acetyltransferase effector conserved across Legionella species targets the eukaryotic eIF3 complex to modulate protein translation
mBio · 2024
DOI: 10.1128/mbio.03221-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Lukas Syriste und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Legionella, Legionella pneumophila, Legionnaires' Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, Canadian Government | Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
The survival of Legionella spp. as intracellular pathogens relies on the combined action of protein effectors delivered inside their eukaryotic hosts by the Dot/Icm ( d efective in o rganelle t rafficking/ i ntra c ellular m ultiplication) type IVb secretion system. The specific repertoire of effector arsenals varies dramatically across over 60 known species of this genera with Legionella pneumophila responsible for most cases of Legionnaires’ disease in humans encoding over 360 Dot/Icm effectors. However, a small subset of “core” effectors appears to be conserved across all Legionella species raising an intriguing question of their role in these bacteria’s pathogenic strategy, which for most of these effectors remains unknown. L. pneumophila Lpg0103 effector, also known as VipF, represents one of the core effector families that features a tandem of Gcn5-related N-acetyltransferase (GNAT) domains. Here, we present the crystal structure of the Lha0223, the VipF representative from Legionella hackeliae in complex with acetyl-coenzyme A determined to 1.75 Å resolution. Our structural analysis suggested that this effector family shares a common fold with the two GNAT domains forming a deep groove occupied by residues conserved across VipF homologs. Further analysis suggested that only the C-terminal GNAT domain of VipF effectors retains the active site composition compatible with catalysis, whereas the N-terminal GNAT domain binds the ligand in a non-catalytical mode. We confirmed this by in vitro enzymatic assays which revealed VipF activity not only against generic small molecule substrates, such as chloramphenicol, but also against poly-L-lysine and histone-derived peptides. We identified the human eukaryotic translation initiation factor 3 (eIF3) complex co-precipitating with Lpg0103 and demonstrated the direct interaction between the several representatives of the VipF family, including Lpg0103 and Lha0223 with the K subunit of eIF3. According to our data, these interactions involve primarily the C-terminal tail of eIF3-K containing two lysine residues that are acetylated by VipF. VipF catalytic activity results in the suppression of eukaryotic protein translation in vitro , revealing the potential function of VipF “core” effectors in Legionella ’s pathogenic strategy. IMPORTANCE By translocating effectors inside the eukaryotic host cell, bacteria can modulate host cellular processes in their favor. Legionella species, which includes the pneumonia-causing Legionella pneumophila, encode a widely diverse set of effectors with only a small subset that is conserved across this genus. Here, we demonstrate that one of these conserved effector families, represented by L. pneumophila VipF (Lpg0103), is a tandem Gcn5-related N-acetyltransferase interacting with the K subunit of human eukaryotic initiation factor 3 complex. VipF catalyzes the acetylation of lysine residues on the C-terminal tail of the K subunit, resulting in the suppression of eukaryotic translation initiation factor 3-mediated protein translation in vitro . These new data provide the first insight into the molecular function of this pathogenic factor family common across Legionellae .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
- Department of Chemical Engineering and Applied Chemistry, Toronto University, Toronto, Ontario, Canada.
ORCID-Profile: Deepak T Patel, Alexei Savchenko
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- Canadian Government | Natural Sciences and Engineering Research Council of Canada
- Alberta Graduate Excellence Scholarship
- Canadian Government | Canadian Institutes of Health Research
Zitieren
APA
Syriste, L., Patel, D. T., Stogios, P. J., Skarina, T., Patel, D., & Savchenko, A. (2024). An acetyltransferase effector conserved across Legionella species targets the eukaryotic eIF3 complex to modulate protein translation. mBio. https://doi.org/10.1128/mbio.03221-23
Vancouver
Syriste L, Patel DT, Stogios PJ, Skarina T, Patel D, Savchenko A. An acetyltransferase effector conserved across Legionella species targets the eukaryotic eIF3 complex to modulate protein translation. mBio. 2024. doi:10.1128/mbio.03221-23
BibTeX
@article{Syriste2024,
author = {Syriste, Lukas and Patel, Deepak T and Stogios, Peter J and Skarina, Tatiana and Patel, Dhruvin and Savchenko, Alexei},
title = {An acetyltransferase effector conserved across Legionella species targets the eukaryotic eIF3 complex to modulate protein translation},
journal = {mBio},
year = {2024},
doi = {10.1128/mbio.03221-23}
}
EUVIMED